Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Assets Average (2016 - 2025)

Historic Assets Average for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $863.8 million.

  • Tg Therapeutics' Assets Average rose 7500.0% to $863.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $863.8 million, marking a year-over-year increase of 7500.0%. This contributed to the annual value of $453.6 million for FY2024, which is 7342.28% up from last year.
  • As of Q3 2025, Tg Therapeutics' Assets Average stood at $863.8 million, which was up 7500.0% from $679.7 million recorded in Q2 2025.
  • Over the past 5 years, Tg Therapeutics' Assets Average peaked at $863.8 million during Q3 2025, and registered a low of $195.5 million during Q1 2023.
  • Moreover, its 5-year median value for Assets Average was $387.3 million (2024), whereas its average is $420.4 million.
  • Per our database at Business Quant, Tg Therapeutics' Assets Average soared by 34337.68% in 2021 and then plummeted by 4787.09% in 2022.
  • Quarter analysis of 5 years shows Tg Therapeutics' Assets Average stood at $394.7 million in 2021, then crashed by 47.87% to $205.7 million in 2022, then soared by 60.56% to $330.3 million in 2023, then surged by 76.14% to $581.9 million in 2024, then skyrocketed by 48.46% to $863.8 million in 2025.
  • Its Assets Average was $863.8 million in Q3 2025, compared to $679.7 million in Q2 2025 and $617.2 million in Q1 2025.